BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Arbaizar B, Gómez-acebo I, Llorca J. Efficacy of topiramate in bulimia nervosa and binge-eating disorder: a systematic review. General Hospital Psychiatry 2008;30:471-5. [DOI: 10.1016/j.genhosppsych.2008.02.002] [Cited by in Crossref: 35] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Micioni Di Bonaventura MV, Ubaldi M, Liberati S, Ciccocioppo R, Massi M, Cifani C. Caloric restriction increases the sensitivity to the hyperphagic effect of nociceptin/orphanin FQ limiting its ability to reduce binge eating in female rats. Psychopharmacology (Berl) 2013;228:53-63. [PMID: 23455592 DOI: 10.1007/s00213-013-3013-0] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
2 Antel J, Hebebrand J. Weight-Reducing Side Effects of the Antiepileptic Agents Topiramate and Zonisamide. In: Joost H, editor. Appetite Control. Berlin: Springer Berlin Heidelberg; 2012. pp. 433-66. [DOI: 10.1007/978-3-642-24716-3_20] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
3 Buoli M, Grassi S, Ciappolino V, Serati M, Altamura AC. The Use of Zonisamide for the Treatment of Psychiatric Disorders: A Systematic Review. Clin Neuropharmacol 2017;40:85-92. [PMID: 28195838 DOI: 10.1097/WNF.0000000000000208] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Sakae K, Suka M, Yanagisawa H. Polaprezinc (Zinc-L-Carnosine Complex) as an Add-on Therapy for Binge Eating Disorder and Bulimia Nervosa, and the Possible Involvement of Zinc Deficiency in These Conditions: A Pilot Study. J Clin Psychopharmacol 2020;40:599-606. [PMID: 33044355 DOI: 10.1097/JCP.0000000000001284] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Wan F, Chang H, Kao Y, Tzeng N. Topiramate Augmentation in the Treatment of a Patient With Schizophrenia and Paraphilia Behaviors. American Journal of Therapeutics 2019;26:e788-9. [DOI: 10.1097/mjt.0000000000000964] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Gadde KM, Apolzan JW, Berthoud HR. Pharmacotherapy for Patients with Obesity. Clin Chem 2018;64:118-29. [PMID: 29054924 DOI: 10.1373/clinchem.2017.272815] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 5.2] [Reference Citation Analysis]
7 Bonnot O, Cohen D, Thuilleaux D, Consoli A, Cabal S, Tauber M. Psychotropic treatments in Prader-Willi syndrome: a critical review of published literature. Eur J Pediatr 2016;175:9-18. [PMID: 26584571 DOI: 10.1007/s00431-015-2670-x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
8 Medeiros GC, Grant JE. Pharmacological Interventions in Gambling Disorder. In: Heinz A, Romanczuk-seiferth N, Potenza MN, editors. Gambling Disorder. Cham: Springer International Publishing; 2019. pp. 171-80. [DOI: 10.1007/978-3-030-03060-5_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Hay P, Chinn D, Forbes D, Madden S, Newton R, Sugenor L, Touyz S, Ward W. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of eating disorders. Aust N Z J Psychiatry. 2014;48:977-1008. [PMID: 25351912 DOI: 10.1177/0004867414555814] [Cited by in Crossref: 266] [Cited by in F6Publishing: 193] [Article Influence: 38.0] [Reference Citation Analysis]
10 Dalai SS, Adler S, Najarian T, Safer DL. Study protocol and rationale for a randomized double-blinded crossover trial of phentermine-topiramate ER versus placebo to treat binge eating disorder and bulimia nervosa. Contemp Clin Trials 2018;64:173-8. [PMID: 29038069 DOI: 10.1016/j.cct.2017.10.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
11 Muratore AF, Attia E. Psychopharmacologic Management of Eating Disorders. Curr Psychiatry Rep 2022. [PMID: 35576089 DOI: 10.1007/s11920-022-01340-5] [Reference Citation Analysis]
12 Rocha-González HI, De la Cruz-Álvarez LE, Kammar-García A, Canizales-Quinteros S, Huerta-Cruz JC, Barranco-Garduño LM, Reyes-García JG. Weight Loss at First Month and Development of Tolerance as Possible Predictors of 30 mg Phentermine Efficacy at 6 Months. J Pers Med 2021;11:1354. [PMID: 34945825 DOI: 10.3390/jpm11121354] [Reference Citation Analysis]
13 Svaldi J, Schmitz F, Baur J, Hartmann AS, Legenbauer T, Thaler C, von Wietersheim J, de Zwaan M, Tuschen-Caffier B. Efficacy of psychotherapies and pharmacotherapies for Bulimia nervosa. Psychol Med 2019;49:898-910. [PMID: 30514412 DOI: 10.1017/S0033291718003525] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
14 D’addario C, Micioni Di Bonaventura M, Pucci M, Romano A, Gaetani S, Ciccocioppo R, Cifani C, Maccarrone M. Endocannabinoid signaling and food addiction. Neuroscience & Biobehavioral Reviews 2014;47:203-24. [DOI: 10.1016/j.neubiorev.2014.08.008] [Cited by in Crossref: 80] [Cited by in F6Publishing: 69] [Article Influence: 10.0] [Reference Citation Analysis]
15 Safer DL, Adler S, Dalai SS, Bentley JP, Toyama H, Pajarito S, Najarian T. A randomized, placebo‐controlled crossover trial of phentermine‐topiramate ER in patients with binge‐eating disorder and bulimia nervosa. Int J Eat Disord 2020;53:266-77. [DOI: 10.1002/eat.23192] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
16 Amianto F, Ottone L, Abbate Daga G, Fassino S. Binge-eating disorder diagnosis and treatment: a recap in front of DSM-5. BMC Psychiatry 2015;15:70. [PMID: 25885566 DOI: 10.1186/s12888-015-0445-6] [Cited by in Crossref: 60] [Cited by in F6Publishing: 37] [Article Influence: 8.6] [Reference Citation Analysis]
17 Micioni Di Bonaventura MV, Vitale G, Massi M, Cifani C. Effect of Hypericum perforatum Extract in an Experimental Model of Binge Eating in Female Rats. J Obes 2012;2012:956137. [PMID: 22997570 DOI: 10.1155/2012/956137] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
18 Castillo M, Weiselberg E. Bulimia Nervosa/Purging Disorder. Current Problems in Pediatric and Adolescent Health Care 2017;47:85-94. [DOI: 10.1016/j.cppeds.2017.02.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 2.6] [Reference Citation Analysis]
19 Pinto EC, Dolzan MD, Cabral LM, Armstrong DW, de Sousa VP. Topiramate: a review of analytical approaches for biological matrices: A review of bioanalytical methods for topiramate. Biomed Chromatogr 2015;29:1461-72. [DOI: 10.1002/bmc.3466] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
20 Fontenelle LF, Oostermeijer S, Harrison BJ, Pantelis C, Yücel M. Obsessive-Compulsive Disorder, Impulse Control Disorders and Drug Addiction: Common Features and Potential Treatments. Drugs 2011;71:827-40. [DOI: 10.2165/11591790-000000000-00000] [Cited by in Crossref: 95] [Cited by in F6Publishing: 82] [Article Influence: 8.6] [Reference Citation Analysis]
21 Peng XX, Ziff EB, Carr KD. Effects of food restriction and sucrose intake on synaptic delivery of AMPA receptors in nucleus accumbens. Synapse 2011;65:1024-31. [PMID: 21425350 DOI: 10.1002/syn.20931] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
22 Álvarez Ruiz EM, Gutiérrez-rojas L. Comorbilidad entre el trastorno bipolar y los trastornos de la conducta alimentaria. Revista de Psiquiatría y Salud Mental 2015;8:232-41. [DOI: 10.1016/j.rpsm.2014.12.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
23 Pinto EC, Dolzan MD, Cabral LM, Armstrong DW, de Sousa VP. Topiramate: A Review of Analytical Approaches for the Drug Substance, Its Impurities and Pharmaceutical Formulations. J Chromatogr Sci 2016;54:280-90. [PMID: 26276847 DOI: 10.1093/chromsci/bmv120] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
24 Consoli A, Çabal Berthoumieu S, Raffin M, Thuilleaux D, Poitou C, Coupaye M, Pinto G, Lebbah S, Zahr N, Tauber M, Cohen D, Bonnot O. Effect of topiramate on eating behaviours in Prader-Willi syndrome: TOPRADER double-blind randomised placebo-controlled study. Transl Psychiatry 2019;9:274. [PMID: 31685813 DOI: 10.1038/s41398-019-0597-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
25 Winkelman JW, Wipper B, Purks J, Mei L, Schoerning L. Topiramate reduces nocturnal eating in sleep-related eating disorder. Sleep 2020;43:zsaa060. [DOI: 10.1093/sleep/zsaa060] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
26 Maggioni F, Mampreso E, Mainardi F, Lisotto C, Malvindi ML, Zanchin G. Topiramate-Induced Intractable Cough During Migraine Prophylaxis. Headache: The Journal of Head and Face Pain 2010;50:301-4. [DOI: 10.1111/j.1526-4610.2009.01515.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
27 Poitou C, Ciangura C. Traitement des obésités communes. EMC - Endocrinologie - Nutrition 2009;6:1-11. [DOI: 10.1016/s1155-1941(09)51422-9] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
28 Sinclair LI, Dineen PT, Malizia AL. Modulation of ion channels in clinical psychopharmacology: adults and younger people. Expert Rev Clin Pharmacol 2010;3:397-416. [PMID: 22111619 DOI: 10.1586/ecp.10.21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
29 Cifani C, Micioni Di Bonaventura MV, Vitale G, Ruggieri V, Ciccocioppo R, Massi M. Effect of salidroside, active principle of Rhodiola rosea extract, on binge eating. Physiol Behav 2010;101:555-62. [PMID: 20837037 DOI: 10.1016/j.physbeh.2010.09.006] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 3.4] [Reference Citation Analysis]
30 Waller G. Recent advances in therapies for the eating disorders. F1000 Med Rep 2009;1:38. [PMID: 20948743 DOI: 10.3410/M1-38] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]